Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718891 | SCV000719733 | likely benign | not provided | 2021-02-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000635373 | SCV000756782 | benign | Carnitine palmitoyltransferase II deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003226339 | SCV003922503 | likely benign | not specified | 2023-03-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451408 | SCV004179572 | likely benign | Encephalopathy, acute, infection-induced, susceptibility to, 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451405 | SCV004179573 | likely benign | Carnitine palmitoyl transferase II deficiency, severe infantile form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451407 | SCV004179574 | likely benign | Carnitine palmitoyl transferase II deficiency, neonatal form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451406 | SCV004180551 | likely benign | Carnitine palmitoyl transferase II deficiency, myopathic form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927980 | SCV004741103 | likely benign | CPT2-related condition | 2019-11-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |